Martek's life'sDHA(TM) Approved for Food Use in China

Martek's life'sDHA(TM) Approved for Food Use in China

August 24, 2007

    COLUMBIA, Md., Aug. 23 /Xinhua-PRNewswire/ -- Martek
Biosciences, a DHA omega-3 market leader, announced today
that the Ministry of Health in China has authorized the use
of the company's life'sDHA(TM) as a novel food ingredient. 
This new designation will permit the immediate use of
Martek's life'sDHA(TM) in foods, beverages and supplements
in China for persons older than twelve months. Since 2001,
Martek's life'sDHA(TM) and life'sARA(TM) (arachidonic
acid), an omega-6 fatty acid, have been used in infant
formula throughout China.   

    DHA (docosahexaenoic acid) omega-3 is a long-chain
omega-3 fatty acid that serves as a primary building block
for the brain and the eyes and supports brain, eye and
cardiovascular health throughout life. There is a large and
growing body of scientific evidence demonstrating that
people of all ages, from infants to aging adults, benefit
from an adequate supply of DHA omega-3 in their diets.
Scientific reviews have noted the importance of DHA omega-3
in proper brain and eye function, and there are studies
currently underway to investigate its role in decreasing
the prevalence of certain neurological disorders.

    Martek's life'sDHA(TM) is unique in the market because
it is derived from a sustainable and vegetarian source.
Made from microalgae under tightly controlled manufacturing
conditions, life'sDHA(TM) is free of oceanic contaminants
that may be present in certain fish or fish oils.
Microalgae are the only vegetarian source of DHA omega-3,
the key omega-3 for brain and eye development and function.

    Martek opened a representative office in Shanghai
earlier this year.  Qingdao Samuels Industrial and
Commercial Company, Ltd. has been appointed as Martek's
distributor for life'sDHA(TM) in China. Samuels will be
responsible for the selling and distribution activities
surrounding life'sDHA(TM) in food (excluding infant
formula), beverage and supplement applications in China,
Hong Kong and Macao.  Additional details and contact
information for Samuels may be obtained at
http://www.samuels.cn or from Martek.  

    This initial approval by the Ministry of Health is part
of the regulatory process applicable to Chinese novel foods
and continues through August 5, 2009.  Martek may then
apply for a final novel food certificate.    

    Martek Biosciences Corporation (Nasdaq: MATK) is a
leader in the innovation and development of DHA omega-3
products that promote health and wellness through every
stage of life. The company produces life'sDHA(TM), a
sustainable and vegetarian source of the omega-3 fatty acid
DHA (docosahexaenoic acid), for use in foods, beverages,
infant formula, and supplements. The company also produces
life'sARA(TM) (arachidonic acid), an omega-6 fatty acid,
from a sustainable, vegetarian source, for use in infant
formula. For more information on Martek Biosciences
Corporation, visit http://www.martek.com. 

    Sections of this release contain forward-looking
statements. These statements are based upon numerous
assumptions which Martek cannot control and involve risks
and uncertainties that could cause actual results to
differ. These statements should be understood in light of
the risk factors set forth in the company's filings with
the Securities and Exchange Commission, including, but not
limited to, the company's Form 10-K for the fiscal year
ended October 31, 2006 and other filed reports on Form
10-K, Form 10-K/A, Form 10-Q and Form 8-K.  



    For more information, please contact:

     Kyle Stults
     Investor Relations 
     Phone:   [phone]
     Email:   [e-mail]

     Website: http://www.martekbio.com 
              http://www.samuels.cn